| Study Period | 2021 - 2032 |
| Market Size in 2025 | USD 38.1 Billion |
| Market Size in 2026 | USD 40.7 Billion |
| Market Size by 2032 | USD 63.5 Billion |
| Projected CAGR | 7.6% |
| Largest Region | North America |
| Fastest-Growing Region | Asia-Pacific |
| Market Structure | Fragmented |
Explore the market potential with our data-driven report
The anatomic pathology market size will be an estimated USD 38.1 billion for 2025, and it will grow by 7.6% during 2026–2032, to reach USD 63.5 billion by 2032.
The market growth is primarily driven by the growing need for precision and speed in diagnosing cancer and other chronic conditions, which are expanding the global burden of disease. Therefore, the demand for anatomic pathology to examine tissues and organs through microscopy will continue to grow, as it currently represents one of the most direct methods to achieve this goal.
New technologies are changing how anatomic pathology workflows are conducted and evaluated through the use of artificial intelligence, digital image systems, and automated analytical platforms. And, as such, they offer a means to enhance the efficiency and accessibility of pathology services and to reduce the time required for the provision of diagnostic information. The availability of biomarker-based diagnostic testing and companion diagnostic testing platforms also has the potential to expand the market for anatomic pathology by providing a mechanism for delivering targeted treatments to individual patients based on their unique molecular characteristics.
The consumables category holds the largest market share, of 65%, in 2025, due to the majority of consumable products, such as reagents, antibodies, stains, and specialized kits used in routine pathological testing, being repeatedly used in various types of anatomic pathology tests, such as histopathology, immunohistochemistry, and molecular, performed in all pathology laboratories. The repeated purchase of consumables is a reflection of their necessary use in anatomic pathology testing workflows across all pathology laboratories.
The instruments category will have the highest CAGR, due to increased use of technology and upgrades to laboratory infrastructure. Digital pathology scanners, automated tissue processors and high-resolution imaging systems represent large capital expenditures which increase the efficiency of laboratory operations and improve the ability to conduct diagnostics in pathology laboratories. Additionally, the incorporation of artificial intelligence (AI) enabled analytical tools and telepathology platforms into pathology laboratories will also drive the adoption of new instruments in health care institutions.
The products analyzed in this report are:
The histopathology category holds the largest market share, of 60%, in 2025, and is considered to be the most widely used anatomic pathology technique. Histopathology is the microscopic examination of tissue samples to determine if there are any structural changes or disease-related changes present in the tissue sample being examined. Histopathology is essential for diagnosing diseases and conditions of tissues and organs and is used across all areas of medical specialties and is therefore expected to generate strong demand for products and services associated with this technique.
The cytopathology category will have the highest CAGR, of 7.9%, as it has been increasingly used in the early detection of cancers and other conditions using minimally invasive diagnostic methods. The use of liquid-based cytology techniques, fine needle aspiration procedures, cervical cancer screening programs, and the increased use of molecular testing with cytological samples will drive the growth of the cytopathology segment.
The types analyzed in this report are:
The special staining category holds the largest market share, of 45%, in 2025, due to the importance of special staining techniques in the characterization of tissues and the diagnosis of diseases. Special staining techniques provide pathologists with the capability to highlight specific structures of cells, identify microorganisms, and differentiate between different tissue components utilizing selective staining protocols. Due to the variety and specificity of special staining techniques they are a necessary tool utilized by pathologists in all pathology subspecialties.
The immunohistochemistry category will have the highest CAGR, as it uses the interaction between an antibody and an antigen to detect specific proteins in tissue samples, thereby providing pathologists with the ability to precisely identify cellular markers that are important for the diagnosis, classification, and selection of therapy for cancers. The development of new antibodies and automated staining platforms will further expand the capabilities of immunohistochemistry.
The techniques analyzed in this report are:
The disease diagnosis category holds the largest market share, of 70%, in 2025, due to widespread use of anatomic pathology in the diagnosis of cancer, inflammation, infections and degenerative diseases will result in continuous demand for diagnostic services. Anatomic pathology provides critical information for treatment planning, assessment of prognosis and management of patients across all medical specialties.
The drug discovery category will have the highest CAGR, of 7.8%, reflecting increased investment by the pharmaceutical industry in research on biomarkers and development of companion diagnostics. Anatomic pathology supports preclinical research, endpoints for clinical trials, and regulatory submissions utilizing standard protocols for analyzing tissue samples. Integration of digital pathology and AI-enabled analysis platforms will further support the capabilities of pharmaceutical companies and accelerate the time it takes to develop drugs.
The applications analyzed in this report are:
The hospitals & clinics category holds the largest market share, of 50%, in 2025. Hospitals and clinics are the major providers of pathology services to integrated healthcare delivery systems. As part of these systems, hospitals and clinics operate large pathology departments supporting the clinical activities, patient care, and diagnostic needs of multiple medical specialties. The quantity and diversity of pathology samples processed in hospital-based laboratories will create a consistent need for products and services related to anatomic pathology.
The diagnostic laboratories category will have the highest CAGR, driven by increasing contracting of pathology services and the need for specialized testing. Independent pathology laboratories provide expert services in complex molecular testing, digital pathology services and subspecialty consultation that supplement the capabilities provided by hospital-based pathology laboratories. The efficiency and cost effectiveness of centralizing laboratory operations will support continued growth in the independent diagnostic laboratory segment.
The end users analyzed in this report are:
Drive strategic growth with comprehensive market analysis
North America holds the largest market share, of 45%, in 2025, due to the fact that North America has a well-developed healthcare system, a large number of research studies are being conducted there, and a high rate of adoption of innovative anatomic pathology technologies and methods. The presence of several major players such as Quest Diagnostics, LabCorp, and key instrument vendors provides a strong competitive advantage in the region.
In North America, the United States is the largest market. Based on estimates provided by the American Cancer Society, approximately 2 million cancer patients will be diagnosed in the United States in 2025; therefore, the demand for pathology services is expected to be very strong.
The U.S. Food and Drug Administration (FDA) has been providing regulatory support for digital pathology and artificial intelligence (AI)-enabled diagnostic tools; thereby accelerating the adoption of these technologies. In addition, several platforms have received FDA clearance for primary diagnosis. Furthermore, the Federal Government has established two programs that provide funding for genomic research and personalized medicine development: the Precision Medicine Initiative and the Cancer Moonshot Program. These programs have strengthened the overall market fundamentals in the anatomic pathology space.
Canada is also a significant growth opportunity within North America, as Canada is growing healthcare investments, and aging population demographics are expected to create strong demand for pathology services. A universal healthcare system exists in Canada; therefore, comprehensive cancer screening programs and diagnostic services are available to all Canadian citizens, which will provide consistent demand for anatomic pathology products and services across each province's network of health organizations.
Asia-Pacific will have the highest CAGR, of 7.7%, due to the rapidly expanding healthcare infrastructure and increasing disease burdens in the region. With approximately 60 percent of the world's population residing in the Asia-Pacific region, along with rapidly developing economies such as China and India, the anatomic pathology market presents a substantial business opportunity for pathology service providers.
China reported the largest patient population in the region and one of the largest healthcare systems by total volume; therefore, it has the largest market share in the Asia-Pacific region. The World Health Organization (WHO) reported that China had the largest global cancer burden at 4.57 million new cancer diagnoses in 2020. The Chinese government has committed to modernizing and digitizing the country's healthcare systems, which will result in continued market growth in terms of diagnostic infrastructure.
Japan has a mature pathology market; however, there is a focus on technological innovation and precision medicine applications. Japan's aging population and high standards for healthcare result in a need for highly advanced pathology services, and Japanese companies play a significant role in the global development of instruments and technologies for pathology.
The regions and countries of the market are as follows:
The market is a fragmented, competitive environment that includes many large, well-established players as well as smaller, newer technology-based companies. Leading market participants maintain their positions through continuous investment in digital pathology platforms, AI-enabled diagnostics, and automated laboratory workflows. As a result of the need for laboratories, technology companies and pharmaceutical companies to create comprehensive diagnostic platforms, strategic alliances among these types of entities have increased in importance. By partnering with each other, they can utilize their respective capabilities to create a comprehensive solution, as well as share the cost of research and development and the associated risk.
Want a report tailored exactly to your business need?
Request CustomizationLeading companies across industries trust us to deliver data-driven insights and innovative solutions for their most critical decisions. From data-driven strategies to actionable insights, we empower the decision-makers who shape industries and define the future. From Fortune 500 companies to innovative startups, we are proud to partner with organisations that drive progress in their industries.
Working with P&S Intelligence and their team was an absolute pleasure – their awareness of timelines and commitment to value greatly contributed to our project's success. Eagerly anticipating future collaborations.
McKinsey & Company
India
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws
Customize the Report to Align with Your Business Objectives
Request the Free Sample Pages